Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Dandy Partners with Yeshiva University's New College of Dental Medicine to Power the Future of Digital Dentistry Education
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Dandy, the fully digital dental lab, today announced a partnership with Yeshiva University's new College of Dental Medicine, the first new dental school to open in New York City in over 100 years.
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
GlobeNewswire, Inc.
MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today reports business...
Starget Pharma Expands Scientific Advisory Board with Appointment of Two Global Leaders in Radiopharmaceutical Therapy
GlobeNewswire, Inc.
Dr. Oliver Sartor brings more than 35 years advancing the clinical development and commercialization of oncology and radiopharmaceuticals Professor Michael Hofman brings more than 20 years pioneering molecular imaging and precision...
REGN DEADLINE: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
GlobeNewswire, Inc.
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) that a securities class action has been filed on behalf of shareholders who purchased Regeneron securities...
SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
GlobeNewswire, Inc.
U.S. publication of a patent application covering the MDMA-N-acylethanolamines combination expands intellectual property generated through the collaboration, and provides guidance addressing clinical development considerations for psychedelic...
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
GlobeNewswire, Inc.
TYLER, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced the...
Constellation Group Joins Select Global Leaders Advancing a New International Standard for Healthier Homes
EIN Presswire
CORA Merrick Park becomes Florida’s first condominium to participate in the International WELL Building Institute’s new WELL for residential Program CORAL GABLES, FL, UNITED STATES, July 23, 2026 /EINPresswire.com/ -- Constellation Group and The...
San Antonio Research Commands meet with Israeli Foreign Trade Representatives at VelocityTX
DVIDS - Georgia
SAN ANTONIO – Research directors from Naval Medical Research Unit (NAMRU) San Antonio, U.S. Army Institute of Surgical Research, and U.S. Air Force 59th Medical Wing met with representatives from the Houston-based TradeIL South-Midwest USA of...
Chrysolite Aesthetics Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
HOUSTON, TX, UNITED STATES, July 22, 2026 /EINPresswire.com/ -- Chrysolite Aesthetics is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
The Lane Spa Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
PALM BEACH GARDENS, FL, UNITED STATES, July 22, 2026 /EINPresswire.com/ -- The Lane Spa is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
GlobeNewswire, Inc.
WEST CHESTER, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers,...
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
GlobeNewswire, Inc.
PolyPid to potentially receive over $320 million in upfront and milestone payments, including $30 million in upfront and near-term milestone payments, plus tiered royalties ranging from mid-teen to mid-twenties percentages Azurity, a private...
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
GlobeNewswire, Inc.
HINGHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, will be participating at this year’s Society of Robotic Surgery (SRS) annual...
$5 Million Gift Establishes Colton Center for Autoimmunity at Mount Sinai to Advance Precision Medicine for Autoimmune Diseases
GlobeNewswire, Inc.
New York, NY, July 21, 2026 (GLOBE NEWSWIRE) -- A $5 million gift from philanthropists Judith and Stewart Colton will establish a Colton Center for Autoimmunity within the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM) at the...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
GlobeNewswire, Inc.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
GlobeNewswire, Inc.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
GlobeNewswire, Inc.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
GlobeNewswire, Inc.
PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended...
BrainsWay Announces Strategic Investment in Radial Health, Inc.
GlobeNewswire, Inc.
BURLINGTON, Mass. and JERUSALEM, July 20, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced a $3 million minority...
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.